Travis Morgan, President and CFO of DecisionRx touts medication optimization as the way to improve outcomes and reduce costs. In this episode, Travis shares his journey from an entrepreneurial upbringing to making waves in the life sciences and healthcare technology sectors. Learn how his experiences in public accounting and as a precision medicine company co-founder have shaped his unique approach to tackling one of the healthcare industry's most costly issues: ineffective medications.

Hear how DecisionRx is leveraging pharmacogenomics and data science to improve patient outcomes and reduce healthcare expenses. Travis explains the impact of pharmacist-led interventions , and how the value-based care model, combined with genetic analysis, can guides clinical decision to prevent medication failures. Get insights into the commercial success of this approach, particularly within risk-bearing entities like ACOs and Medicare Advantage plans.

Learn about the power of innovative medication optimization, eliminating the usual friction associated with third-party reimbursement. Travis discusses the company's scale-up effort, with over 230,000 lives under contract through accountable care organizations and substantial financial backing from the Carlyle Group.

Finally, hear why Travis recommends "Endurance: The Biography of Ernest Shackleton," as an essential read for any aspiring leader.

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.

Curious about the forces driving healthcare pricing and access? Join us for an enlightening conversation with Sarah Emond, President and CEO of the Institute for Clinical and Economic Review (ICER). Sarah's upbringing in a family passionate about policy and social justice laid the foundation for her impactful career in health policy. We explore her educational journey from Smith College to Brandeis University’s Heller School, and how her professional experiences in clinical research and biopharmaceutical consulting shaped her path to ICER.

Unravel the complex world of health technology assessment (HTA) in the US as Sarah breaks down the challenges and opportunities within a fragmented healthcare system. ICER's pivotal role in evaluating new medical technologies is discussed in depth, including its interactions with international agencies like the UK's NICE. Sarah sheds light on ICER's evolution from a small initiative within Mass General Hospital to a powerful voice in global HTA practices, emphasizing the importance of fair pricing, patient access, and sustainable innovation funding.

Equity in healthcare takes center stage as Sarah introduces ICER’s updated value assessment framework. Learn about new tools like the clinical trial diversity rating and the Health Improvement Distribution Index (HIDI) designed to promote representation of diverse populations in clinical trials. We also tackle the high costs and value-based pricing of innovative treatments, including gene and cell therapies, and the necessity of evolving payment systems to ensure continuous innovation. Tune in to gain a comprehensive understanding of the pressing challenges and future directions in healthcare pricing, equity, and access.

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.

Eileen McAnenny, the driving force behind the Employer Coalition on Health in Massachusetts shares her journey from a typical Irish Catholic home in Somerville (before it was fashionable) to a leader in healthcare policy and cost management.

Discover how her roots and influential figures like Tip O'Neill and the Kennedys shaped her passion for public service, leading to a law career and roles at the Bank of New England, the Joint Committee on Taxation, and beyond. Eileen's insights on employer engagement in healthcare costs and her work with the Massachusetts Taxpayers Foundation illuminate the challenges and opportunities in controlling this major business expense.

As healthcare costs in Massachusetts continue to balloon, smaller businesses are feeling the pinch more than ever.

This episode delves into the complexities of managing healthcare costs, especially in a state where large healthcare employers wield significant political influence. We explore the role of employer coalitions in bringing balance to the conversation, representing the needs of those tasked with purchasing healthcare, and striving for sustainability against the backdrop of inflation and workforce shortages. Eileen's experience at Fidelity and her focus on employer-related policy issues provide a compelling narrative on the interplay between businesses and healthcare providers.

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.